The therapeutic potential of mitochondrial transplantation for the treatment of neurodegenerative disorders
Author:
Espino De la Fuente-Muñoz César1, Arias Clorinda1
Affiliation:
1. Departamento de Medicina Genómica y Toxicología Ambiental , Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México , AP 70-228 , 04510, Ciudad de México , México
Abstract
Abstract
Mitochondrial activity is essential to support neural functions, and changes in the integrity and activity of the mitochondria can contribute to synaptic damage and neuronal death, especially in degenerative diseases associated with age, such as Alzheimer’s and Parkinson’s disease. Currently, different approaches are used to treat these conditions, and one strategy under research is mitochondrial transplantation. For years, mitochondria have been shown to be transferred between cells of different tissues. This process has allowed several attempts to develop transplantation schemes by isolating functional mitochondria and introducing them into damaged tissue in particular to counteract the harmful effects of myocardial ischemia. Recently, mitochondrial transfer between brain cells has also been reported, and thus, mitochondrial transplantation for disorders of the nervous system has begun to be investigated. In this review, we focus on the relevance of mitochondria in the nervous system, as well as some mitochondrial alterations that occur in neurodegenerative diseases associated with age. In addition, we describe studies that have performed mitochondrial transplantation in various tissues, and we emphasize the advances in mitochondrial transplantation aimed at treating diseases of the nervous system.
Funder
Fundación Miguel Alemán, A.C., UNAM, DGAPA, PAPIIT
Publisher
Walter de Gruyter GmbH
Subject
General Neuroscience
Reference156 articles.
1. Adami, P.V.M., Quijano, C., Magnani, N., Galeano, P., Evelson, P., Cassina, A., Do Carmo, S., Leal, M.C., Castaño, E.M., Cuello, A.C., et al. (2017). Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer’s disease. J. Cerebr. Blood Flow Metabol. 37: 69–84. 2. Ahmad, T., Aggarwal, K., Pattnaik, B., Mukherjee, S., Sethi, T., Tiwari, B.K., Kumar, M., Micheal, A., Mabalirajan, U., Ghosh, B., et al. (2013). Computational classification of mitochondrial shapes reflects stress and redox state. Cell Death Dis. 4: e461–e461. https://doi.org/10.1038/cddis.2012.213. 3. Ahmad, T., Mukherjee, S., Pattnaik, B., Kumar, M., Singh, S., Kumar, M., Rehman, R., Tiwari, B.K., Jha, K.A., Barhanpurkar, A.P., et al. (2014). Miro1 regulates intercellular mitochondrial transport & amp: enhances mesenchymal stem cell rescue efficacy. EMBO J. 33. https://doi.org/10.1002/embj.201386030. 4. Al Amir Dache, Z., Otandault, A., Tanos, R., Pastor, B., Meddeb, R., Sanchez, C., Arena, G., Lasorsa, L., Bennett, A., Grange, T., et al. (2020). Blood contains circulating cell-free respiratory competent mitochondria. Faseb. J. 34: 3616–3630. https://doi.org/10.1096/fj.201901917rr. 5. Alikhani, N., Ankarcrona, M., and Glaser, E. (2009). Mitochondria and Alzheimer’s disease: amyloid-β peptide uptake and degradation by the presequence protease. hPreP. J. Bioenerg. Biomembr. 41: 447–451, https://doi.org/10.1007/s10863-009-9244-4.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|